Related news: Novo Nordisk's Recombinant Coagulation Factor Ⅷ Applied for Marketing Ahead of Chiatai Tianqing!
Coagulation factor Ⅷ marketed in China includes the first generation, second generation, and third generation, wherein, Chinese pharmaceutical enterprises mainly market the first generation, and overseas pharmaceutical enterprises market the second and third generations. Roche's Emicizumab Injection has been marketed in China since the end of last year, which attracts much attention. As a recombinant humanized bispecific monoclonal antibody, emicizumab was approved by the U.S. FDA for marketing at the end of 2017; the drug has a longer action time compared to other hemophilia drugs and requires only one subcutaneous injection every week, being the only long-acting recombinant coagulation factor Ⅷ marketed in China at present.

Classification | Pharmaceutical enterprise | Pharmaceutical product name | Product specification |
First generation | Shanghai RAAS | Lyophilized Human Coagulation Factor Ⅷ Concentrate | 200IU, 300IU, 400IU |
Human Coagulation Factor Ⅷ | 200IU, 300IU | ||
Lyophilized Human Coagulation Factor Ⅷ | 200IU, 300IU | ||
Hualan Bio | Human Coagulation Factor Ⅷ | 200IU, 300IU, 400IU | |
Lyophilized Human Coagulation Factor Ⅷ Concentrate | 200IU, 300IU, 400IU | ||
Lyophilized Human Coagulation Factor Ⅷ | 200IU, 300IU, 240IU | ||
Green Cross | Human Coagulation Factor Ⅷ | 200IU | |
Lyophilized Human Coagulation Factor Ⅷ | 100IU, 200IU | ||
Lyophilized Human Coagulation Factor Ⅷ Concentrate | 200IU | ||
China Biologic | Lyophilized Human Coagulation Factor Ⅷ | 200IU, 300IU | |
Human Coagulation Factor Ⅷ | 200IU, 300IU | ||
Biological Pharmaceutical | Human Coagulation Factor Ⅷ | 200IU | |
Second generation | Baxter | Lyophilized Human Coagulation Factor Ⅷ | 250IU, 500IU |
Recombinant Human Coagulation Factor Ⅷ for Injection (powder injection) | Read More
Previous:
The Latest on Caffeine Limits
Related News
Made-in-China New Drugs: The Game and Breakthrough in the Over - 4 - Billion Market
Lezhi September 5, 2025
Advancements in the field of synthetic biology in 2023 by ChatGPT
ChatGPT October 20, 2023
MNC ramps up AI pharmaceutical layout, can AI and pharmaceuticals collide to spark "fireworks"?
Yefenghong/PharmaSources October 27, 2023 You may like
Chlorpromazine hydrochloride made in China
Echinacea Extract Chicoric acid Echinacoside
An Echinacea extract Echinacea Echinacea purpurea Echinacea pallida enzymatic echinacea purpurea ext
China New Chemical Substance Notification (China Reach)
China Cheap Price 50L -80℃ Air Cooled Industrial Water Standing Chiller Machine Manufacturer
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Most popular
The Rise of Biosimilars: Regulatory Pathways and Market Outlook
Nurah Ekhlaque
Sep 19, 2025
Methodology Validation in Chinese Pharmacopoeia 2025: How to Report Accuracy and Precision
Xing Xing
Sep 12, 2025
Digitalization in Procurement: From AI Forecasting to Blockchain Traceability
Saher Haider
Sep 19, 2025
|










(All Rights Reserved)